Mesothelioma Web logo



  1. Gene Signature Could Revolutionize Cancer Care
    Discovery should help doctors tailor treatment to specific tumor type, June 2, 2005

  2. Cancer seen in family members of asbestos workers
    People who were exposed to asbestos through a family member who worked with the material appear to run the risk of developing mesothelioma, May 30, 2005

  3. Vitamin E helps battle mesothelioma
    Alpha-TOS, which is closely related to Vitamin E, killed mesothelioma cancer cells in experiments with mice, May 22, 2005

  4. Ex-'silver bullet' re-aimed at cancer
    Formerly hyped anti-angiogenesis drugs that starve tumors show new promise in use with chemotherapy, May 16, 2005

  5. SV40 not implicated in mesothelioma
    Researchers eliminated contamination that has likely been the reason previous studies have implicated SV40, April 6, 2005

  6. New treatment options for some difficult cancers improve survival and quality of life
    Surgery combined with inserting heated chemotherapy drugs directly into the abdomen can improve survival rates, March 7, 2005

  7. Woman Diagnosed With Mesothelioma Gets New Results
    Karen Grant's treatment seems to have had positive results. January 7, 2005

  8. Coramsine offers hope to mesothelioma patients
    Researchers excited about new chemotherapy drug coramsine. November 25, 2004

  9. Coramsine reported effective in treating and preventing mesothelioma in a mouse model of the cancer
    Australia's Solbec Shares Soar After Cancer Drug Find. November 23, 2004, coramsine

  10. No Role For Simian Virus 40 In Human Pleural Mesotheliomas
    Researchers at Memorial Sloan-Kettering Cancer Center found no evidence for a significant role for SV40 in human mesotheliomas

  11. Experimental Surgery Gives Cancer Patient Hope
    Very aggressive combination of surgery and chemotheraphy. September, 2004

  12. Studies Find No Evidence That SV40 is Related to Human Cancer
    Further evidence that exposure to simian virus 40 (SV40) is not associated with mesothelioma in humans. August, 2004

  13. SBP002 Boosts the Immune System
    Press Release from Solbec. June, 2004

  14. Celebrex Hits Mesothelioma, in Lab Studies
    COX-2 inhibitor has an effect on malignant mesothelioma. May 6, 2004

  15. Group Launches Asbestos-Cancer Study
    Karmanos Cancer Center to start new program, April 5, 2004

  16. New Study Reviews Novel Approach to Control Inflammation Using Melanocortin Receptors
    Press Release from Zengen, March 3, 2004

  17. FDA Approves Alimta-Cisplatin Combination for Treatment of Asbestos-Related Cancer Mesothelioma
    Press Release from Eli Lilly, February 5, 2004

  18. FDA Approves First Drug for Rare Type of Cancer
    FDA News: FDA approves Alimta for use in the treatment of patients with malignant pleural mesothelioma, February 5, 2004

  19. Mesothelioma Cancer drug developed by chemistry professor
    Princeton University chemist's discovery of Alimta - a cancer drug with tremendous potential for treating solid tumors, February, 2004

  20. First-ever Blood Test for Mesothelioma Being Developed
    Asbestos Cancer Breakthrough Reported by Pacific Northwest Research Institute, November 13, 2003

  21. New Directions for the Treatment of Mesothelioma
    An Expert Interview With Nicholas J. Vogelzang, MD, June 9, 2003

  22. FDG-PET May Have Prognostic Value in Malignant Pleural Mesothelioma
    Report from ASCO 39th Annual Meeting, June 2, 2003

  23. Novel RAF Kinase Inhibitor Bay 43-9006 Shows Early Signs of Tolerability and Activity
    Press Release from Bayer Pharmaceuticals and Onyx Pharmaceuticals, June 2, 2003

  24. Next Era of Cancer Therapy Aims to Separate Cancer From Blood Supply
    News from M.D. Anderson Cancer Center, May 16, 2003

  25. Breaking news - US

    Breaking news - International


    Read excerpts from medical publications